PAX-8 Expression in Salivary Duct Carcinoma.

Appl Immunohistochem Mol Morphol

State University of New York, Upstate Medical University, Syracuse, NY.

Published: October 2021

AI Article Synopsis

Article Abstract

Salivary duct carcinoma (SDC) is a high-grade adenocarcinoma resembling breast ductal carcinoma. It accounts for ~10% of malignant tumors of the salivary glands. Most cases show expression of CK7 and androgen receptor. PAX-8 is a transcription factor, with expression reported in renal, Müllerian, and thyroid carcinomas. Previous studies have described an absence of PAX-8 immunostaining in most primary salivary gland neoplasms, including SDCs. However, PAX-8 expression is frequently found in neoplasms that can metastasize to salivary glands, suggesting the possibility that this protein can be used to differentiate SDC from secondary neoplastic involvement of the salivary gland. We evaluated the expression of PAX-8 in 14 cases of SDC from our institution. One case showed diffuse moderate to strong PAX-8 positivity, while 2 tumors showed focal weak staining. Therefore, we conclude that although the majority of SDC are negative for PAX-8, rare diffuse positivity can be seen in these primary salivary gland tumors. This could potentially pose difficulty in ruling out metastatic disease from another PAX-8-positive primary neoplasm.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000951DOI Listing

Publication Analysis

Top Keywords

salivary gland
12
pax-8 expression
8
salivary duct
8
duct carcinoma
8
salivary glands
8
primary salivary
8
pax-8
7
salivary
7
expression salivary
4
carcinoma salivary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!